Impact of Non-steroidal Anti-inflammatory Drug Administration for 12 Months on Renal Function
Open Access
- 26 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 2, 644391
Abstract
Background: The use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk of renal complications. Resolution of renal adverse effects after NSAID administration has been observed after short-term use. Thus, the present study aimed to investigate a series of patients with chronic musculoskeletal pain who underwent long-term NSAID administration followed by switching to tramadol hydrochloride/acetaminophen (TA) combination tablets to study the impact of NSAID-induced renal adverse effects.Methods: This was a longitudinal retrospective study of 99 patients with chronic musculoskeletal pain. The patients were administrated with NSAIDs daily during the first 12 months, followed by daily TA combination tablets for 12 months. Estimated glomerular filtration rate (eGFR) and serum levels of aspartate aminotransferase and alanine transaminase were measured at baseline, after NSAID administration and after TA administration.Results: eGFR was significantly reduced after 12-month NSAID administration (median, from 84.0 to 72.8 ml/min/1.73 m2), and the reduction was not shown after the subsequent 12-month TA administration (median, 71.5 ml/min/1.73 m2). Reduction in eGFR was less in patients who received celecoxib (median, −1.8 ml/min/1.73 m2) during the first 12 months. There was no significant difference in aspartate aminotransferase and alanine transaminase in each period.Conclusions: Thus, patients receiving NSAIDs for 12 months displayed both reversible and irreversible reduction of eGFR upon cessation of NSAIDs and switching to TA. Our data highlight the potential safety benefit of utilizing multimodal analgesic therapies to minimize the chronic administration of NSAIDs.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic reviewFamily Practice, 2013
- Therapy Switching, Augmentation, and Discontinuation in Patients with Osteoarthritis and Chronic Low Back PainPain Practice, 2012
- Patterns of Therapy Switching, Augmentation, and Discontinuation After Initiation of Treatment With Select Medications in Patients With OsteoarthritisClinical Therapeutics, 2011
- Epidemiological data, efficacy and safety of a paracetamol–tramadol fixed combination in the treatment of moderate-to-severe pain. SALZA: a post-marketing study in general practiceCurrent Medical Research and Opinion, 2011
- An updated overview of clinical guidelines for the management of non-specific low back pain in primary careEuropean Spine Journal, 2010
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in miceJournal of Clinical Investigation, 2009
- Update on guidelines for the treatment of chronic musculoskeletal painClinical Rheumatology, 2006
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain, 2001